Autolus Therapeutics plc (NASDAQ:AUTL) Q2 2025 Earnings Call Transcript August 12, 2025
Autolus Therapeutics plc beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.24.
Operator: Good day and thank you for standing by. Welcome to the Autolus Therapeutics plc Second Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question and answer session. Please be advised...
